# OpenEvidence

Evidence-based medical AI question-answering engine for physicians.

AI-powered clinical decision support engine providing evidence-based medical answers for healthcare professionals.

Canonical: https://uniquebase.ai/companies/openevidence
Stable identifier: UB-C1898
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T20:25:35.668Z

## Funding

Listed 3 records.
Latest: $250M (Series D), 2026-01-21.

- 2026-09-27 · amount unavailable · Andreessen Horowitz, DST Global, Google Ventures, Kleiner Perkins, NVIDIA, Sequoia Capital, Thrive Capital · https://www.businessinsider.com/chatgpt-for-medicine-openevidence-fielding-valuation-2026-9
  > On 2026/9/27, Business Insider reported that OpenEvidence, a US medical AI search company, reached a valuation of USD 15 billion after completing USD 250 million in funding. (translated source brief)
- 2026-01-21 · $250M · Series D · DST Global, Google Ventures, Greycroft, Henry Kravis, ICONIQ Capital, Kleiner Perkins, Mayo Clinic, Meritech Capital Partners, Nvidia GPU Ventures, Sequoia Capital, Thrive Capital
  > On 2026-01-21, according to Xiniu Data, OpenEvidence completed Series D financing, raising USD 250 million. Investors were Nvidia GPU Ventures, Henry Kravis, Mayo Clinic, DST and others. (translated source brief)
- 2025-10-23 · $200M · Blackstone, Bond Capital, Coatue, Craft Ventures, Google Ventures, Kleiner Perkins, Sequoia Capital, Thrive Capital · https://www.nytimes.com/2025/10/20/business/dealbook/openevidence-fundraising-chatgpt-medicine.html
  > On 2025/10/23, NYT reported that medical AI search company OpenEvidence had raised USD 200 million at a USD 6 billion valuation. It did not disclose specific investors or revenue and focuses on evidence-based medical Q&A for doctors and researchers. (translated source brief)

## Valuation

Listed 3 records.
Latest: $6B, 2025-10-23.

- 2026-09-27 · amount unavailable · Andreessen Horowitz, DST Global, Google Ventures, Kleiner Perkins, NVIDIA, Sequoia Capital, Thrive Capital · https://www.businessinsider.com/chatgpt-for-medicine-openevidence-fielding-valuation-2026-9
  > On 2026/9/27, Business Insider reported that OpenEvidence, a US medical AI search company, reached a valuation of USD 15 billion after completing USD 250 million in funding. (translated source brief)
- 2026-01-21 · amount unavailable · Series D · DST Global, Google Ventures, Greycroft, Henry Kravis, ICONIQ Capital, Kleiner Perkins, Mayo Clinic, Meritech Capital Partners, Nvidia GPU Ventures, Sequoia Capital, Thrive Capital
  > On 2026-01-21, according to Xiniu Data, OpenEvidence completed Series D financing, raising USD 250 million. Investors were Nvidia GPU Ventures, Henry Kravis, Mayo Clinic, DST and others. (translated source brief)
- 2025-10-23 · $6B · Blackstone, Bond Capital, Coatue, Craft Ventures, Google Ventures, Kleiner Perkins, Sequoia Capital, Thrive Capital · https://www.nytimes.com/2025/10/20/business/dealbook/openevidence-fundraising-chatgpt-medicine.html
  > On 2025/10/23, NYT reported that medical AI search company OpenEvidence had raised USD 200 million at a USD 6 billion valuation. It did not disclose specific investors or revenue and focuses on evidence-based medical Q&A for doctors and researchers. (translated source brief)

## Revenue

Listed 3 records.
Latest: $300M (ARR), 2026-07-21.

- 2026-07-21 · $300M (ARR) · https://www.linkedin.com/posts/dr-lucas-mittelmeier_not-enough-people-are-talking-about-this-share-7485233191688151040-bbN5/
  > On 2026/7/21, LinkedIn reported that US medical AI question-answering platform OpenEvidence had reached USD 300 million ARR, with approximately 860 thousand clinician users. (translated source brief)
- 2025-12-18 · $150M (ARR) · https://x.com/kapilansh_twt/status/2000993510888280501
  > On 2025/12/18, X reported that medical AI search company OpenEvidence had reached USD 150 million in annual recurring revenue. It did not disclose its latest funding or valuation. (translated source brief)
- 2025-07-17 · $50M (ARR) · https://www.linkedin.com/posts/rik-renard_openevidence-just-went-from-1b-to-35b-activity-7351262524446580736-TRrq
  > On 2025/7/17, LinkedIn reported that AI scientific search platform OpenEvidence had disclosed USD 50 million in annual recurring revenue. (translated source brief)

## Team

- [Daniel Nadler](/people/daniel-nadler)

## Products

- [OpenEvidence](/products/openevidence)

## Investors

- [Andreessen Horowitz](/institutions/andreessen-horowitz)
- [Blackstone](/institutions/blackstone)
- [Bond Capital](/institutions/bond-capital)
- [Coatue](/institutions/coatue)
- [Craft Ventures](/institutions/craft-ventures)
- [DST Global](/institutions/dst-global)
- [Google Ventures](/institutions/google-ventures)
- [Greycroft](/institutions/greycroft)
- [Henry Kravis](/institutions/henry-kravis)
- [ICONIQ Capital](/institutions/iconiq-capital)
- [Kleiner Perkins](/institutions/kleiner-perkins)
- [Mayo Clinic](/institutions/mayo-clinic)
- [Meritech Capital Partners](/institutions/meritech-capital-partners)
- [NVIDIA](/institutions/nvidia)
- [Nvidia GPU Ventures](/institutions/nvidia-gpu-ventures)
- [Sequoia Capital](/institutions/sequoia-capital)
- [Thrive Capital](/institutions/thrive-capital)

## Sources

- No source links are available for this profile.